Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report No. 36

JAMA Ophthalmology

Volumn 132, Issue 3, 2014, Pages 272-277

  Chew, Emily Y ^a   Clemons, Traci E ^b   Agrón, Elvira ^a   Sperduto, Robert D ^b   SanGiovanni, John Paul ^a   Davis, Matthew D ^c   Ferris III, Frederick L ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CUPRIC OXIDE; PLACEBO; ZINC OXIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUSEN; EYE EXAMINATION; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SMOKING; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHIC ATROPHY; HUMANS; MALE; MIDDLE AGED; RETINAL DRUSEN; RISK FACTORS; VISION DISORDERS; VISUAL ACUITY; VITAMINS; WET MACULAR DEGENERATION;

EID: 84896282942     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.6636     Document Type: Article

References (9)

1. Friedman DS, O'Colmain BJ, Muñoz B, et al Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572. (Pubitemid 38456293)
2. Wang JJ, Rochtchina E, Lee AJ, et al. Ten-year incidence and progression of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 2007;114(1):92-98. (Pubitemid 46014292)
3. Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007;114(2):253-262. (Pubitemid 46161820)
4. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report No. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
5. Chew EY, Clemons TE, Agrón E, et al Age-Related Eye Disease Study Research Group.Long-term effects of vitamins C, E, β-carotene and zinc on age-related macular degeneration in the Age-Related Eye Disease Study: AREDS report No. 35. Ophthalmology. 2013;120(8):1604-11.e4. doi:10.1016/j.ophtha.2013. 01.021.
6. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications: AREDS report No. 1. Control Clin Trials. 1999;20(6):573-600.
7. Age-Related Eye Disease Study Research Group. The AREDS system for classifying age-related macular degeneration from stereoscopic color fundus photographs: AREDS report No. 6. Am J Ophthalmol. 2001;132(5):668-681.
8. Ferris FL, Davis MD, Clemons TE, et al Age-Related Eye Disease Study (AREDS) Research Group. A simplified severity scale for age-related macular degeneration: AREDS report No. 18. Arch Ophthalmol. 2005;123(11):1570-1574. (Pubitemid 41626694)
9. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111(7):1280-1287. (Pubitemid 38844822)